| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 556,229 | 411,830 | 433,602 | 498,565 | | Cost of Revenue | 489,589 | 374,048 | 403,717 | 513,760 | | | Gross Profit | 66,640 | 37,782 | 29,885 | (15,195) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 50,076 | 45,847 | 45,652 | 43,082 | | Non Recurring | 1,530 | (2,196) | 1,789 | (7,869) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,034 | (5,869) | (17,556) | (50,408) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 620 | 5,634 | 872 | 279 | | Earnings Before Interest And Taxes | 16,843 | (235) | (16,684) | (50,129) | | Interest Expense | 519 | 629 | 840 | 1,354 | | Income Before Tax | 16,324 | (864) | (17,524) | (51,483) | | Income Tax Expense | 5,907 | 114 | (10,604) | (17,234) | | Minority Interest | (152) | (548) | (46) | 247 | | | | Net Income From Continuing Ops | 10,265 | (1,526) | (6,966) | (34,002) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,265 | (1,526) | (6,966) | (34,002) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,265 | ($1,526) | ($6,966) | ($34,002) |
|
0.12% Nasdaq 
Income Statement
